Published in J Virol on December 16, 2009
Virulence of Newcastle disease virus: what is known so far? Vet Res (2011) 1.18
Elements in the canine distemper virus M 3' UTR contribute to control of replication efficiency and virulence. PLoS One (2012) 0.84
Development and application of reporter-expressing mononegaviruses: current challenges and perspectives. Antiviral Res (2014) 0.83
Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations. PLoS One (2013) 0.78
Molecular basis for the thermostability of Newcastle disease virus. Sci Rep (2016) 0.77
Constraints on the Genetic and Antigenic Variability of Measles Virus. Viruses (2016) 0.77
The deletion of an extra six nucleotides in the 5' -untranslated region of the nucleoprotein gene of Newcastle disease virus NA-1 decreases virulence. BMC Vet Res (2014) 0.75
Sustaining Interferon Induction by a High-Passage Atypical Porcine Reproductive and Respiratory Syndrome Virus Strain. Sci Rep (2016) 0.75
Translation of human hepatitis C virus RNA in cultured cells is mediated by an internal ribosome-binding mechanism. J Virol (1993) 5.08
Recovery of infectious SV5 from cloned DNA and expression of a foreign gene. Virology (1997) 3.58
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
Recovery of a virulent strain of newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology (2000) 2.39
Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication. Virology (1996) 2.03
The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol (2004) 1.79
Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol (2005) 1.61
Nonsegmented negative-strand viruses as vaccine vectors. J Virol (2006) 1.53
A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol (2004) 1.41
The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol (2008) 1.20
End-to-end communication in the modulation of translation by mammalian RNA viruses. Virus Res (2005) 1.20
Optimization of human immunodeficiency virus gag expression by newcastle disease virus vectors for the induction of potent immune responses. J Virol (2008) 1.17
Adding genes to the RNA genome of vesicular stomatitis virus: positional effects on stability of expression. J Virol (2002) 1.15
Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology (2009) 1.09
Analysis of the noncoding regions of measles virus strains in the Edmonston vaccine lineage. J Virol (2001) 1.08
Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus. J Virol (2009) 1.06
Recombinant Newcastle disease virus as a viral vector: effect of genomic location of foreign gene on gene expression and virus replication. J Gen Virol (2003) 0.98
Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog (2004) 3.14
The hemagglutinin-neuraminidase protein of Newcastle disease virus determines tropism and virulence. J Virol (2004) 1.79
Newcastle disease virus V protein is associated with viral pathogenesis and functions as an alpha interferon antagonist. J Virol (2003) 1.73
Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol (2005) 1.72
Complete genome sequence of avian paramyxovirus type 3 reveals an unusually long trailer region. Virus Res (2008) 1.63
Molecular characterization and complete genome sequence of avian paramyxovirus type 4 prototype strain duck/Hong Kong/D3/75. Virol J (2008) 1.50
A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol (2004) 1.41
Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A (2007) 1.39
Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death. J Virol (2006) 1.37
Complete genome sequence of avian paramyxovirus type 7 (strain Tennessee) and comparison with other paramyxoviruses. Virus Res (2009) 1.36
Complete genome sequence of avian paramyxovirus (APMV) serotype 5 completes the analysis of nine APMV serotypes and reveals the longest APMV genome. PLoS One (2010) 1.31
Complete genome sequence of a novel Newcastle disease virus strain isolated from a chicken in West Africa. J Virol (2012) 1.30
Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/Wakuya/20/78. Virus Res (2009) 1.30
Complete genome sequences of avian paramyxovirus serotype 6 prototype strain Hong Kong and a recent novel strain from Italy: evidence for the existence of subgroups within the serotype. Virus Res (2010) 1.29
Complete sequence of the genome of avian paramyxovirus type 2 (strain Yucaipa) and comparison with other paramyxoviruses. Virus Res (2008) 1.27
Roles of the fusion and hemagglutinin-neuraminidase proteins in replication, tropism, and pathogenicity of avian paramyxoviruses. J Virol (2011) 1.23
Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine (2010) 1.20
Complete sequence of the genome of avian paramyxovirus type 9 and comparison with other paramyxoviruses. Virus Res (2009) 1.20
The large polymerase protein is associated with the virulence of Newcastle disease virus. J Virol (2008) 1.20
Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of Indonesia. J Virol (2012) 1.18
Role of intergenic sequences in newcastle disease virus RNA transcription and pathogenesis. J Virol (2007) 1.15
Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin-neuraminidase protein. J Virol (2004) 1.13
Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology (2012) 1.11
Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol (2009) 1.08
Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One (2009) 1.08
Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy. J Virol (2010) 1.07
Loss of N-linked glycosylation from the hemagglutinin-neuraminidase protein alters virulence of Newcastle disease virus. J Virol (2004) 1.06
Role of untranslated regions of the hemagglutinin-neuraminidase gene in replication and pathogenicity of newcastle disease virus. J Virol (2009) 1.06
Complete genome sequence of highly virulent neurotropic Newcastle disease virus strain Texas GB. Virus Genes (2010) 1.03
Phylogenetic and pathotypic characterization of newcastle disease viruses circulating in west Africa and efficacy of a current vaccine. J Clin Microbiol (2012) 1.01
A single amino acid change, Q114R, in the cleavage-site sequence of Newcastle disease virus fusion protein attenuates viral replication and pathogenicity. J Gen Virol (2011) 1.00
Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain. PLoS One (2012) 1.00
Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine (2009) 0.99
Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. J Virol (2011) 0.96
Replication, neurotropism, and pathogenicity of avian paramyxovirus serotypes 1-9 in chickens and ducks. PLoS One (2012) 0.96
A Y526Q mutation in the Newcastle disease virus HN protein reduces its functional activities and attenuates virus replication and pathogenicity. J Virol (2009) 0.95
The MHC class II-associated invariant chain interacts with the neonatal Fc gamma receptor and modulates its trafficking to endosomal/lysosomal compartments. J Immunol (2008) 0.94
Complete genome sequence of a virulent Newcastle disease virus isolated from an outbreak in chickens in Egypt. Virus Genes (2009) 0.93
Complete genome sequence of avian paramyxovirus-3 strain Wisconsin: evidence for the existence of subgroups within the serotype. Virus Res (2010) 0.93
Newcastle disease virus expressing human immunodeficiency virus type 1 envelope glycoprotein induces strong mucosal and serum antibody responses in Guinea pigs. J Virol (2011) 0.92
Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1). Vaccine (2012) 0.92
Mutations in the fusion protein cleavage site of avian paramyxovirus serotype 2 increase cleavability and syncytium formation but do not increase viral virulence in chickens. J Virol (2011) 0.92
Evaluation of the genetic diversity of avian paramyxovirus type 4. Virus Res (2012) 0.91
Complete genome sequence of an avian paramyxovirus type 4 from north america reveals a shorter genome and new genotype. Genome Announc (2013) 0.90
The pathogenesis of Newcastle disease: a comparison of selected Newcastle disease virus wild-type strains and their infectious clones. Virology (2006) 0.90
Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine. PLoS One (2013) 0.88
Complete sequence of the G glycoprotein gene of avian metapneumovirus subgroup C and identification of a divergent domain in the predicted protein. J Gen Virol (2004) 0.88
A host-restricted viral vector for antigen-specific immunization against Lyme disease pathogen. Vaccine (2011) 0.88
Deduced amino acid sequence of the small hydrophobic protein of US avian pneumovirus has greater identity with that of human metapneumovirus than those of non-US avian pneumoviruses. Virus Res (2003) 0.88
Experimental infection of mice with avian paramyxovirus serotypes 1 to 9. PLoS One (2011) 0.87
Recovery of avian metapneumovirus subgroup C from cDNA: cross-recognition of avian and human metapneumovirus support proteins. J Virol (2006) 0.86
Sequence analysis of fusion protein gene of Newcastle disease virus isolated from outbreaks in Egypt during 2006. Virol J (2011) 0.86
Complete genome sequences of avian paramyxovirus serotype 2 (APMV-2) strains Bangor, England and Kenya: evidence for the existence of subgroups within serotype 2. Virus Res (2010) 0.86
Experimental avian paramyxovirus serotype-3 infection in chickens and turkeys. Vet Res (2010) 0.85
The interferon antagonistic activities of the V proteins from two strains of Newcastle disease virus correlate with their known virulence properties. Virus Res (2009) 0.84
Processing enzyme glucosidase II: proposed catalytic residues and developmental regulation during the ontogeny of the mouse mammary gland. Glycobiology (2004) 0.84
Identification of simian agent 10 as human parainfluenza virus type 3 suggests transmission of a human virus to an African monkey. J Virol (2010) 0.84
Cell-type-specific innate immune response to oncolytic Newcastle disease virus. Viral Immunol (2012) 0.83
Mutations in the cytoplasmic domain of the Newcastle disease virus fusion protein confer hyperfusogenic phenotypes modulating viral replication and pathogenicity. J Virol (2013) 0.83
Pathogenesis of two strains of avian paramyxovirus serotype 2, Yucaipa and Bangor, in chickens and turkeys. Avian Dis (2010) 0.82
Prostate-specific antigen-retargeted recombinant newcastle disease virus for prostate cancer virotherapy. J Virol (2013) 0.81
Comparative immunogenicity of HIV-1 gp160, gp140 and gp120 expressed by live attenuated newcastle disease virus vector. PLoS One (2013) 0.81
Role of the cytoplasmic tail amino acid sequences of Newcastle disease virus hemagglutinin-neuraminidase protein in virion incorporation, cell fusion, and pathogenicity. J Virol (2009) 0.81
Sequence analysis of the large polymerase (L) protein of the US strain of avian metapneumovirus indicates a close resemblance to that of the human metapneumovirus. Virus Res (2004) 0.81
Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9. Vet Res (2011) 0.80
Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus. Hum Vaccin Immunother (2015) 0.79
Contribution of the attachment G glycoprotein to pathogenicity and immunogenicity of avian metapneumovirus subgroup C. Avian Dis (2010) 0.78
Experimental infection of calves with Newcastle disease virus induces systemic and mucosal antibody responses. Arch Virol (2008) 0.78
Analysis of the complete genome sequence of avian metapneumovirus subgroup C indicates that it possesses the longest genome among metapneumoviruses. Virus Genes (2005) 0.78
Inhibition of host innate immune responses and pathogenicity of recombinant Newcastle disease viruses expressing NS1 genes of influenza A viruses. J Gen Virol (2010) 0.77
Evaluation of the replication, pathogenicity, and immunogenicity of avian paramyxovirus (APMV) serotypes 2, 3, 4, 5, 7, and 9 in rhesus macaques. PLoS One (2013) 0.77
Complete genome sequence of a highly virulent newcastle disease virus currently circulating in Mexico. Genome Announc (2013) 0.77
Role of C596 in the C-terminal extension of the haemagglutinin-neuraminidase protein in replication and pathogenicity of a highly virulent Indonesian strain of Newcastle disease virus. J Gen Virol (2013) 0.76